Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT00097214 · COMPLETED
Trial details
- NCT number
- NCT00097214
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-11-01
- Primary completion
- 2007-04-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.